Table 1 Recipient baseline and clinical characteristics of ex vivo lung perfusion (EVLP) lung transplantations (LTX) and conventional LTx
Variables | EVLP-LTx (n = 6) | Conventional-LTx (n = 15) | p-value |
|---|---|---|---|
Weight (kg) | 70.7 ± 19.3 | 59. 1 ± 7.9 | 0.060 |
Height (cm) | 170.8 ± 11.8 | 169.9 ± 10.1 | 0.862 |
BMI | 24.0 ± 5.3 | 20.5 ± 3.5 | 0.088 |
Male | 3 (50%) | 6 (40%) | 0.523 |
Age (years) | 54.1 ± 10.4 | 42.6 ± 14.8 | 0.100 |
Waiting list (days) | 49.0 (7–174) | 44 (4–389) | 0.785 |
Pre-op Life support | |||
Mechanical ventilation | 0 (0.00%) | 1 (6.66%) | 0.714 |
ECMO | 0 (0.00%) | 1 (6.66%) | 0.750 |
Major indication | 0.407 | ||
COPD | 3 (50.00%) | 5 (33.33%) | |
AAT1 | 1 (16.66%) | 0 (0.00%) | |
PH | 0 (0.00%) | 1 (6.66%) | |
CF | 1 (16.66%) | 7 (46.66%) | |
PF | 1 (16.66%) | 1 (6.66%) | |
LAM | 0 (0.00%) | 1 (6.66%) | |
Lab values | |||
FVC (liters) | 2.0 ± 0.4 | 1.0 ± 0.6 | 0.540 |
FEV1 (liters) | 0.8 ± 10.4 | 54.1 ± 10.4 | 0.516 |
6MWT (%) | 39.6 ± 21.4 | 45.9 ± 25.1 | 0.600 |
P-ALT (μkat/L) | 0.41 ± 0.15 | 0.32 ± 10.4 | 0.181 |
P-AST (μkat/L) | 0.46 ± 0.12 | 0.41 ± 0.11 | 0.443 |
P-creatinine (μmol/L) | 64.4 ± 11.5 | 54.1 ± 15.8 | 0. 216 |
Tx-type | |||
SLTx | 0 (0%) | 0 (0%) | |
DLTx | 6 (100%) | 15 (100%) | |
HLTx | 0 (0%) | 0 (0%) | |
Re-LTx | 0 (0%) | 0 (0%) | |